Survival rates for resin bonded bridges

Resin-bonded bridges for the pediatric patient.

The resin-bonded bridge is a relatively new clinical technique that has had favorable clinical reports. Recently, new materials and techniques have been developed which may improve the retention of resin-bonded bridges. This article reviews recent developments concerning resin-bonded bridges, present a case report, and give practical suggestions regarding the fabrication of resin-bonded bridges.

Long-term survival data from a clinical trial on resin-bonded bridges.

OBJECTIVES A clinical trial, involving 203 resin-bonded bridges (RBBs) was undertaken to investigate the influence of retainer-type and luting material on the survival of these restorations. METHODS For this evaluation, 157 patients were available (14% of the original sample was lost to follow-up or excluded from the study following the stopping criteria). Fifty per cent of the patients were ...

A systematic review of the survival and complication rates of resin-bonded bridges after an observation period of at least 5 years.

OBJECTIVES The objectives of this systematic review were to assess the 5-year survival of resin-bonded bridges (RBBs) and to describe the incidence of technical and biological complications. METHODS An electronic Medline search complemented by manual searching was conducted to identify prospective and retrospective cohort studies on RBBs with a mean follow-up time of at least 5 years. Patient...

A modified technique for direct, fibre-reinforced, resin-bonded bridges: clinical case reports.

This article presents new modifications to the clinical technique of fabricating directly applied resin-bonded fibre-reinforced bridges. Torsional and flexural strength is achieved by means of a reinforced polyethylene fibre ribbon substructure surrounded by laminated layers of microhybrid and microfilled resins. The modifications provide a simple method for creating a better pontic-ridge relat...

Anterior etched cast-resin bonded bridges: an alternative for adolescent patients.